KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Free Cash Flow (2016 - 2025)

Zimmer Biomet Holdings has reported Free Cash Flow over the past 17 years, most recently at $442.6 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $442.6 million for Q4 2025, down 2.68% from a year ago — trailing twelve months through Dec 2025 was $1.5 billion (up 13.66% YoY), and the annual figure for FY2025 was $1.5 billion, up 13.66%.
  • Free Cash Flow for Q4 2025 was $442.6 million at Zimmer Biomet Holdings, up from $363.7 million in the prior quarter.
  • Over the last five years, Free Cash Flow for ZBH hit a ceiling of $525.6 million in Q4 2023 and a floor of $172.9 million in Q1 2024.
  • Median Free Cash Flow over the past 5 years was $322.4 million (2024), compared with a mean of $324.4 million.
  • Peak annual rise in Free Cash Flow hit 649.3% in 2021, while the deepest fall reached 51.86% in 2021.
  • Zimmer Biomet Holdings' Free Cash Flow stood at $288.4 million in 2021, then crashed by 37.31% to $180.8 million in 2022, then soared by 190.71% to $525.6 million in 2023, then dropped by 13.47% to $454.8 million in 2024, then dropped by 2.68% to $442.6 million in 2025.
  • The last three reported values for Free Cash Flow were $442.6 million (Q4 2025), $363.7 million (Q3 2025), and $328.1 million (Q2 2025) per Business Quant data.